NEFFY Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Neffy, and when can generic versions of Neffy launch?

Neffy is a drug marketed by Ars Pharms Operation and is included in one NDA. There are seven patents protecting this drug.

This drug has seventy patent family members in twenty-eight countries.

The generic ingredient in NEFFY is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Neffy

A generic version of NEFFY was approved as epinephrine by BPI LABS on July 29^th, 2014.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NEFFY?
What are the global sales for NEFFY?
What is Average Wholesale Price for NEFFY?

Summary for NEFFY

International Patents:	70
US Patents:	7
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
What excipients (inactive ingredients) are in NEFFY?	NEFFY excipients list
DailyMed Link:	NEFFY at DailyMed

Drug patent expirations by year for NEFFY

Pharmacology for NEFFY

Drug Class	Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists Adrenergic beta-Agonists

US Patents and Regulatory Information for NEFFY

NEFFY is protected by seven US patents.

Patents protecting NEFFY

Compositions for drug administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Intranasal epinephrine formulations and methods for the treatment of disease
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

Compositions for drug administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for NEFFY

See the table below for patents covering NEFFY around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Russian Federation	2554814	КОМПОЗИЦИИ ДЛЯ ВВЕДЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ (COMPOSITIONS FOR DRUG INTRODUCTION)	⤷ Sign Up
Mexico	2023002506	FORMULACIONES DE EPINEFRINA INTRANASAL Y METODOS PARA EL TRATAMIENTO DE ENFERMEDADES. (INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE.)	⤷ Sign Up
Brazil	PI0923403	composições para administração de fármaco	⤷ Sign Up
Eurasian Patent Organization	202091615	ИНТРАНАЗАЛЬНЫЕ СОСТАВЫ НА ОСНОВЕ ЭПИНЕФРИНА И СПОСОБЫ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for NEFFY

Pharmacology for NEFFY

Patents protecting NEFFY

Make Better Decisions: Try a trial or see plans & pricing